Neuilly-sur-Seine, France

Pierre Langlade Demoyen

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Pierre Langlade Demoyen: Innovator in Biotechnology and Immunology

Introduction

Pierre Langlade Demoyen, based in Neuilly-sur-Seine, France, is a prominent inventor in the fields of biotechnology and immunology, holding a remarkable total of 16 patents. His work focuses on developing innovative therapies that target key mechanisms in human diseases, particularly in cancer and immune response modulation.

Latest Patents

Among his latest inventions is a Telomerase Encoding DNA Vaccine. This invention comprises a nucleic acid construct that encodes a human telomerase reverse transcriptase (hTERT) protein which lacks telomerase catalytic activity and a nucleolar localization signal. This construct is designed to trigger an immune response in subjects against cells that overexpress telomerase, primarily targeting dysplastic or tumor cells.

Another significant patent involves Anti HLA-G Specific Antibodies. This invention pertains to antibodies or antigen-binding fragments specifically directed against the human leukocyte antigen-G (HLA-G) protein. They are generated against an immunogenic peptide derived from the α3 domain of the HLA-G protein, along with methods for producing these antibodies.

Career Highlights

Pierre Langlade Demoyen has made pivotal contributions to the biopharmaceutical industry through his work at companies like Invectys and Invectys SA. His innovative approaches have not only advanced scientific understanding but also propelled the development of therapeutic solutions.

Collaborations

Throughout his career, Demoyen has collaborated with various professionals, including notable coworkers like Maria Loustau and Julien Caumartin. Their collective expertise has fostered a dynamic research environment that leverages shared knowledge for innovative outcomes.

Conclusion

Pierre Langlade Demoyen's contributions to biotechnology and immunology underscore the importance of innovation in addressing complex health challenges. His patents reflect a forward-thinking approach that could lead to significant advancements in cancer treatment and immune therapies. As he continues to push the boundaries of science, his work remains influential in both academic and commercial settings.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…